West Pharmaceutical Services Stock Price, News & Analysis (NYSE:WST)

$86.58 -0.18 (-0.21 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$86.58
Today's Range$85.86 - $87.22
52-Week Range$77.97 - $103.36
Volume536,795 shs
Average Volume449,633 shs
Market Capitalization$6.44 billion
P/E Ratio43.51
Dividend Yield0.65%
Beta1.04

About West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services logoWest Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company's segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNYSE:WST
CUSIP95530610
Phone610-594-2900

Debt

Debt-to-Equity Ratio0.15%
Current Ratio2.59%
Quick Ratio1.87%

Price-To-Earnings

Trailing P/E Ratio43.5075376884422
Forward P/E Ratio30.27
P/E Growth2.15

Sales & Book Value

Annual Sales$1.60 billion
Price / Sales4.02
Cash Flow$3.46 per share
Price / Cash24.99
Book Value$15.27 per share
Price / Book5.67

Profitability

Trailing EPS$1.99
Net Income$150.70 million
Net Margins9.42%
Return on Equity14.79%
Return on Assets10.01%

Miscellaneous

Employees7,100
Outstanding Shares74,250,000

West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Thursday, February 15th. Investors of record on Wednesday, April 18th will be given a dividend of $0.14 per share on Wednesday, May 2nd. This represents a $0.56 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date of this dividend is Tuesday, April 17th. View West Pharmaceutical Services' Dividend History.

How will West Pharmaceutical Services' stock buyback program work?

West Pharmaceutical Services declared that its board has approved a stock buyback plan on Thursday, February 15th 2018, which permits the company to repurchase 800,000 outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company's board of directors believes its shares are undervalued.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services Inc. (NYSE:WST) announced its earnings results on Thursday, February, 15th. The medical instruments supplier reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.62 by $0.02. The medical instruments supplier had revenue of $415.60 million for the quarter, compared to the consensus estimate of $416.90 million. West Pharmaceutical Services had a net margin of 9.42% and a return on equity of 14.79%. The business's revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.54 earnings per share. View West Pharmaceutical Services' Earnings History.

When will West Pharmaceutical Services make its next earnings announcement?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Wednesday, April, 25th 2018. View Earnings Estimates for West Pharmaceutical Services.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services issued an update on its FY18 earnings guidance on Thursday, February, 15th. The company provided earnings per share (EPS) guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.90. The company issued revenue guidance of $1.72-1.73 billion, compared to the consensus revenue estimate of $1.73 billion.

Where is West Pharmaceutical Services' stock going? Where will West Pharmaceutical Services' stock price be in 2018?

5 brokerages have issued twelve-month target prices for West Pharmaceutical Services' stock. Their forecasts range from $98.00 to $115.00. On average, they expect West Pharmaceutical Services' stock price to reach $106.80 in the next year. View Analyst Ratings for West Pharmaceutical Services.

Who are some of West Pharmaceutical Services' key competitors?

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:

  • Eric Mark Green, President, Chief Executive Officer, Director (Age 47)
  • William J. Federici, Chief Financial Officer, Senior Vice President, Treasurer (Age 57)
  • Annette F. Favorite, Chief Human Resource Officer, Senior Vice President (Age 52)
  • George Lloyd Miller J.D., Senior Vice President, General Counsel, Corporate Secretary (Age 62)
  • Karen A. Flynn, Senior Vice President and Chief Commercial Officer (Age 54)
  • David A. Montecalvo, Senior Vice President - Global Operations and Supply Chain (Age 51)
  • Eric Resnick, Chief Technology Officer, Vice President (Age 53)
  • Daniel Malone, Vice President, Corporate Controller (Age 55)
  • Michael A. Anderson, Vice President, Treasurer (Age 61)
  • Patrick J. Zenner, Non-Executive Independent Chairman of the Board (Age 70)

Who owns West Pharmaceutical Services stock?

West Pharmaceutical Services' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.39%), Franklin Resources Inc. (5.26%), Alliancebernstein L.P. (2.75%), Bamco Inc. NY (2.42%), William Blair Investment Management LLC (1.71%) and Fisher Asset Management LLC (1.41%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Heino Lennartz, Karen Flynn, Michael A Anderson, Patrick J Zenner, Paula A Johnson, Thomas W Hofmann and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

Who sold West Pharmaceutical Services stock? Who is selling West Pharmaceutical Services stock?

West Pharmaceutical Services' stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Goldman Sachs Group Inc., Eagle Asset Management Inc., Allianz Asset Management GmbH, American Century Companies Inc., GW&K Investment Management LLC, Two Sigma Advisers LP and Renaissance Technologies LLC. Company insiders that have sold West Pharmaceutical Services company stock in the last year include Daniel Malone and William J Federici. View Insider Buying and Selling for West Pharmaceutical Services.

Who bought West Pharmaceutical Services stock? Who is buying West Pharmaceutical Services stock?

West Pharmaceutical Services' stock was bought by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., TCW Group Inc., Carillon Tower Advisers Inc., William Blair Investment Management LLC, BlackRock Inc., Brown Advisory Inc., Schroder Investment Management Group and McCollum Christoferson Group LLC. View Insider Buying and Selling for West Pharmaceutical Services.

How do I buy West Pharmaceutical Services stock?

Shares of West Pharmaceutical Services can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of West Pharmaceutical Services stock can currently be purchased for approximately $86.58.

How big of a company is West Pharmaceutical Services?

West Pharmaceutical Services has a market capitalization of $6.44 billion and generates $1.60 billion in revenue each year. The medical instruments supplier earns $150.70 million in net income (profit) each year or $1.99 on an earnings per share basis. West Pharmaceutical Services employs 7,100 workers across the globe.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]


MarketBeat Community Rating for West Pharmaceutical Services (WST)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  222 (Vote Underperform)
Total Votes:  336
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

West Pharmaceutical Services (NYSE:WST) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.402.402.602.67
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $106.80$106.80$106.00$81.28
Price Target Upside: 6.40% upside6.40% upside5.02% upside18.27% downside

West Pharmaceutical Services (NYSE:WST) Consensus Price Target History

Price Target History for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE:WST) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/24/2018Goldman Sachs GroupInitiated CoverageNeutral -> Neutral$110.00LowView Rating Details
10/27/2017Wells Fargo & CoBoost Price TargetOutperform$105.00 -> $112.00N/AView Rating Details
10/17/2017Bank of AmericaDowngradeBuy -> Neutral$98.00N/AView Rating Details
10/3/2017StephensInitiated CoverageEqual -> Equal Weight$99.00MediumView Rating Details
9/15/2017Jefferies GroupUpgradeHold -> Buy$96.00 -> $115.00HighView Rating Details
12/23/2016Janney Montgomery ScottReiterated RatingBuyN/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

West Pharmaceutical Services (NYSE:WST) Earnings History and Estimates Chart

Earnings by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE WST) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2018N/AView Earnings Details
2/15/2018Q4 2017$0.62$0.64$416.90 million$415.60 millionViewN/AView Earnings Details
10/26/2017Q3 2017$0.53$0.67$386.02 million$398.20 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.65$0.66$406.00 million$397.60 millionViewN/AView Earnings Details
4/27/2017Q1 2017$0.55$0.81$380.42 million$387.70 millionViewN/AView Earnings Details
2/16/2017Q416$0.56$0.54$387.31 million$382.30 millionViewListenView Earnings Details
10/27/2016Q316$0.53$0.53$371.76 million$376.70 millionViewListenView Earnings Details
7/28/2016Q216$0.56$0.59$384.58 million$388.00 millionViewListenView Earnings Details
4/28/2016Q116$0.51$0.53$355.86 million$362.10 millionViewListenView Earnings Details
2/18/2016Q415$0.47$0.47$364.76 million$359.70 millionViewListenView Earnings Details
10/29/2015Q315$0.43$0.44$355.90 million$344.50 millionViewListenView Earnings Details
7/30/2015Q215$0.45$0.47$356.33 million$359.70 millionViewListenView Earnings Details
4/30/2015Q115$0.40$0.45$346.64 million$335.90 millionViewListenView Earnings Details
2/19/2015Q414$0.46$0.45$348.33 million$349.80 millionViewListenView Earnings Details
10/30/2014Q314$0.43$0.44$356.08 million$355.90 millionViewListenView Earnings Details
7/31/2014Q214$0.47$0.52$368.60 million$368.90 millionViewN/AView Earnings Details
5/1/2014Q114$0.41$0.38$340.90 million$346.80 millionViewListenView Earnings Details
2/20/2014Q413$0.38$0.38$348.70 million$342.70 millionViewListenView Earnings Details
10/31/2013Q3 13$0.36$0.39$333.25 million$341.80 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.82$0.86$349.85 million$344.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.86$0.87$344.20 million$339.40 millionViewListenView Earnings Details
2/21/2013Q4 2012$0.56$0.61$318.75 million$321.50 millionViewListenView Earnings Details
11/1/2012Q312$0.50$0.52$306.91 million$303.80 millionViewN/AView Earnings Details
8/2/2012$0.69$0.79ViewN/AView Earnings Details
4/26/2012$0.65$0.83ViewN/AView Earnings Details
2/16/2012$0.55$0.59ViewN/AView Earnings Details
11/1/2011$0.54$0.53ViewN/AView Earnings Details
7/28/2011$0.68$0.62ViewN/AView Earnings Details
4/28/2011$0.62$0.60ViewN/AView Earnings Details
2/17/2011$0.46$0.42ViewN/AView Earnings Details
11/2/2010Q3 2010$0.22$0.23ViewN/AView Earnings Details
8/3/2010Q2 2010$0.31$0.32ViewN/AView Earnings Details
4/29/2010Q1 2010$0.26$0.29ViewN/AView Earnings Details
2/18/2010Q4 2009$0.32$0.33ViewN/AView Earnings Details
11/3/2009Q3 2009$0.27$0.23ViewN/AView Earnings Details
8/4/2009Q2 2009$0.27$0.29ViewN/AView Earnings Details
4/30/2009Q1 2009$0.21$0.21ViewN/AView Earnings Details
2/19/2009Q4 2008$0.27$0.28ViewN/AView Earnings Details
11/4/2008Q3 2008$0.24$0.19ViewN/AView Earnings Details
8/5/2008Q2 2008$0.34$0.37ViewN/AView Earnings Details
5/1/2008Q1 2008$0.36$0.36ViewN/AView Earnings Details
2/21/2008Q4 2007$0.24$0.25ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

West Pharmaceutical Services (NYSE:WST) Earnings Estimates

2018 EPS Consensus Estimate: $2.79
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.66$0.66$0.66
Q2 20181$0.73$0.73$0.73
Q3 20181$0.70$0.70$0.70
Q4 20181$0.70$0.70$0.70
(Earnings estimates data provided by Zacks Investment Research)

Dividends

West Pharmaceutical Services (NYSE:WST) Dividend Information

Next Dividend:5/2/2018
Annual Dividend:$0.56
Dividend Yield:0.65%
Dividend Growth:8.90% (3 Year Average)
Payout Ratio:28.14% (Trailing 12 Months of Earnings)
19.58% (Based on This Year's Estimates)
17.13% (Based on Next Year's Estimates)
Track Record:25 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE:WST) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/15/2018Quarterly$0.144/17/20184/18/20185/2/2018
12/22/2017Quarterly$0.140.56%1/17/20181/18/20182/1/2018
7/20/2017Quarterly$0.140.6%10/17/201710/18/201711/1/2017
5/16/2017quarterly$0.130.54%7/17/20177/19/20178/2/2017
2/16/2017Quarterly$0.134/17/20174/19/20175/3/2017
12/14/2016quarterly$0.130.61%1/13/20171/18/20172/1/2017
9/12/2016quarterly$0.1310/17/201610/19/201611/2/2016
7/6/2016Quarterly$0.127/18/20167/20/20168/3/2016
3/4/2016Quarterly$0.124/18/20164/20/20165/4/2016
12/17/2015Quarterly$0.121/15/20161/20/20162/3/2016
7/15/2015quarterly$0.120.79%10/19/201510/21/201511/4/2015
7/2/2015quarterly$0.110.76%7/20/20157/22/20158/5/2015
2/20/2015quarterly$0.110.82%4/20/20154/22/20155/6/2015
12/22/2014quarterly$0.110.81%1/16/20151/21/20152/4/2015
7/16/2014quarterly$0.1110/20/201410/22/201411/5/2014
7/16/2014quarterly$0.111.11%10/15/201410/19/201411/3/2014
5/8/2014quarterly$0.100.94%7/21/20147/23/20148/6/2014
2/20/2014quarterly$0.100.83%4/21/20144/23/20145/7/2014
12/19/2013quarterly$0.100.81%1/17/20141/22/20142/5/2014
8/1/2013quarterly$0.2010/23/201311/6/2013
5/10/2013quarterly$0.191.16%7/22/20137/24/20138/7/2013
3/15/2013quarterly$0.191.21%4/15/20134/17/20135/1/2013
12/27/2012quarterly$0.191.4%1/18/20131/23/20132/6/2013
(Data available from 1/1/2013 forward)

Insider Trades

West Pharmaceutical Services (NYSE WST) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 94.85%
Insider Trades by Quarter for West Pharmaceutical Services (NYSE:WST)
Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE WST) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/8/2017William J FedericiCFOSell21,000$99.01$2,079,210.00190,493View SEC Filing  
5/18/2017William J. FedericiCFOSell54,996$95.45$5,249,368.20View SEC Filing  
5/2/2017Daniel MaloneVPSell4,124$93.31$384,810.44View SEC Filing  
12/8/2016Patrick J. ZennerDirectorBuy332$84.53$28,063.96View SEC Filing  
10/31/2016Paula A. JohnsonDirectorSell2,466$75.87$187,095.42View SEC Filing  
9/6/2016Karen FlynnSVPSell14,581$83.28$1,214,305.6813,513View SEC Filing  
8/23/2016Paula A JohnsonDirectorSell3,042$81.55$248,075.1038,450View SEC Filing  
6/2/2016Daniel MaloneVPSell3,950$74.95$296,052.5030,666View SEC Filing  
5/25/2016Thomas W HofmannDirectorSell2,466$73.57$181,423.6234,506View SEC Filing  
3/1/2016Michael A AndersonVPSell16,414$63.58$1,043,602.1270,507View SEC Filing  
2/29/2016Thomas W HofmannDirectorSell3,042$62.70$190,733.4034,637View SEC Filing  
2/25/2016Heino LennartzInsiderSell5,680$62.47$354,829.6018,304View SEC Filing  
2/24/2016Heino LennartzInsiderSell19,658$59.45$1,168,668.1020,911View SEC Filing  
2/23/2016Paula A. JohnsonDirectorSell7,800$59.39$463,242.00View SEC Filing  
2/22/2016Warwick BedwellInsiderSell16,042$59.52$954,819.8443,623View SEC Filing  
11/25/2015John E. PaproskiinsiderSell17,560$63.41$1,113,479.6070,288View SEC Filing  
11/12/2015Heino LennartzInsiderSell3,500$61.87$216,545.0015,435View SEC Filing  
11/6/2015Michael A AndersonVPSell3,000$62.18$186,540.0061,497View SEC Filing  
11/5/2015Michael A. AndersonVPSell10,000$61.98$619,800.0064,497View SEC Filing  
11/4/2015Daniel MaloneVPSell4,456$61.65$274,712.4022,627View SEC Filing  
8/17/2015William J FedericiCFOSell52,678$59.72$3,145,930.16View SEC Filing  
5/28/2015Heino LennartzInsiderSell9,584$55.00$527,120.00View SEC Filing  
5/22/2015Karen FlynnInsiderSell3,091$55.24$170,746.84View SEC Filing  
5/21/2015Eric Mark GreenCEOBuy18,300$54.89$1,004,487.00View SEC Filing  
5/18/2015Karen FlynnInsiderSell1,909$55.00$104,995.00View SEC Filing  
5/15/2015Donald E Morel JrCEOSell20,000$54.29$1,085,800.00View SEC Filing  
2/27/2015Richard D LuzziVPSell10,000$54.85$548,500.00View SEC Filing  
2/26/2015Michael A AndersonVPSell4,682$54.93$257,182.26View SEC Filing  
2/25/2015Heino LennartzInsiderSell3,617$54.82$198,283.94View SEC Filing  
2/24/2015John E PaproskiInsiderSell9,282$52.87$490,739.34View SEC Filing  
2/23/2015Heino LennartzInsiderSell21,040$53.40$1,123,536.00View SEC Filing  
2/23/2015Patrick J ZennerDirectorSell12,800$53.69$687,232.00View SEC Filing  
11/26/2014Richard D LuzziVPSell8,000$52.11$416,880.00View SEC Filing  
11/21/2014William J FedericiCFOSell3,000$51.22$153,660.00View SEC Filing  
11/20/2014Donald E Morel JrCEOSell20,000$51.30$1,026,000.00View SEC Filing  
11/13/2014John R GaileyVPSell28,000$52.37$1,466,360.00View SEC Filing  
11/11/2014Michael A AndersonVPSell4,600$51.73$237,958.00View SEC Filing  
11/10/2014Warwick BedwellInsiderSell6,306$49.95$314,984.70View SEC Filing  
8/21/2014Richard D LuzziVPSell10,000$44.07$440,700.00View SEC Filing  
8/20/2014John R GaileyVPSell20,000$43.96$879,200.00View SEC Filing  
8/19/2014Michael A AndersonVPSell9,800$43.41$425,418.00View SEC Filing  
8/18/2014William J FedericiCFOSell38,366$42.56$1,632,856.96View SEC Filing  
8/13/2014Heino LennartzInsiderSell7,555$39.65$299,555.75View SEC Filing  
8/11/2014Heino LennartzInsiderSell11,445$40.00$457,800.00View SEC Filing  
8/7/2014John E PaproskiInsiderSell14,000$40.44$566,160.00View SEC Filing  
5/30/2014Richard D LuzziVPSell22,828$42.17$962,656.76View SEC Filing  
5/29/2014Heino LennartzInsiderSell2,000$43.00$86,000.00View SEC Filing  
2/28/2014Heino LennartzInsiderSell16,044$45.84$735,456.96View SEC Filing  
2/26/2014Patrick J ZennerDirectorSell12,800$46.12$590,336.00View SEC Filing  
2/24/2014Warwick BedwellInsiderSell24,606$47.49$1,168,538.94View SEC Filing  
11/26/2013Donald E Morel JrCEOSell35,000$48.60$1,701,000.00View SEC Filing  
11/22/2013William J FedericiCFOSell36,000$48.34$1,740,240.00View SEC Filing  
11/19/2013Karen FlynnInsiderSell5,500$47.75$262,625.00View SEC Filing  
11/8/2013Michael A AndersonVPSell9,200$46.80$430,560.00View SEC Filing  
11/7/2013Heino LennartzInsiderSell5,102$46.70$238,263.40View SEC Filing  
11/6/2013Michael A AndersonVPSell6,000$46.53$279,180.00View SEC Filing  
11/5/2013John R GaileyVPSell6,000$46.83$280,980.00View SEC Filing  
11/5/2013Warwick BedwellInsiderSell6,304$46.84$295,279.36View SEC Filing  
11/4/2013Richard D LuzziVPSell38,708$46.99$1,818,888.92View SEC Filing  
8/30/2013Donald E Morel JrCEOSell10,000$74.46$744,600.00View SEC Filing  
8/27/2013John R GaileyVPSell13,749$76.77$1,055,510.73View SEC Filing  
8/22/2013L Robert JohnsonDirectorSell1,883$76.81$144,633.23View SEC Filing  
8/14/2013John E PaproskiInsiderSell6,011$79.08$475,349.88View SEC Filing  
8/12/2013Anthony WeltersDirectorSell19,200$78.43$1,505,856.00View SEC Filing  
8/8/2013Michael A AndersonVPSell4,300$78.00$335,400.00View SEC Filing  
5/31/2013Michael A AndersonVPSell4,000$68.94$275,760.00View SEC Filing  
5/28/2013Donald E Morel JrCEOSell10,000$67.87$678,700.00View SEC Filing  
5/24/2013L Robert JohnsonDirectorSell1,700$67.47$114,699.00View SEC Filing  
5/20/2013John R GaileyVPSell9,282$68.54$636,188.28View SEC Filing  
5/17/2013L Robert JohnsonDirectorSell4,000$67.80$271,200.00View SEC Filing  
5/8/2013L Robert JohnsonDirectorSell6,400$64.49$412,736.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

West Pharmaceutical Services (NYSE WST) News Headlines

Source:
DateHeadline
West Pharmaceutical (WST) Presents At RBC Capital Markets Global Healthcare Conference - SlideshowWest Pharmaceutical (WST) Presents At RBC Capital Markets Global Healthcare Conference - Slideshow
seekingalpha.com - February 24 at 9:16 AM
California Public Employees Retirement System Acquires 4,713 Shares of West Pharmaceutical Services Inc. (WST)California Public Employees Retirement System Acquires 4,713 Shares of West Pharmaceutical Services Inc. (WST)
www.americanbankingnews.com - February 24 at 5:10 AM
Q1 2018 EPS Estimates for West Pharmaceutical Services Inc. (WST) Lowered by Jefferies GroupQ1 2018 EPS Estimates for West Pharmaceutical Services Inc. (WST) Lowered by Jefferies Group
www.americanbankingnews.com - February 19 at 1:24 AM
West Pharmaceutical Services Inc. Declares Quarterly Dividend of $0.14 (WST)West Pharmaceutical Services Inc. Declares Quarterly Dividend of $0.14 (WST)
www.americanbankingnews.com - February 16 at 8:02 PM
West Pharmaceutical Services Inc. 2017 Q4 - Results - Earnings Call SlidesWest Pharmaceutical Services Inc. 2017 Q4 - Results - Earnings Call Slides
seekingalpha.com - February 15 at 4:33 PM
West Pharmaceutical Services (WST) to Repurchase 800,000 Outstanding Stock West Pharmaceutical Services (WST) to Repurchase 800,000 Outstanding Stock
www.americanbankingnews.com - February 15 at 11:16 AM
West Pharmaceutical Services (WST) Releases FY18 Earnings GuidanceWest Pharmaceutical Services (WST) Releases FY18 Earnings Guidance
www.americanbankingnews.com - February 15 at 10:08 AM
West Pharmaceutical Services (WST) Releases Quarterly  Earnings Results, Beats Estimates By $0.01 EPSWest Pharmaceutical Services (WST) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - February 15 at 10:08 AM
West Pharmaceutical to restructure manufacturingWest Pharmaceutical to restructure manufacturing
www.marketwatch.com - February 15 at 8:46 AM
West Announces Fourth-Quarter and Full-Year 2017 Results and Announces Quarterly DividendWest Announces Fourth-Quarter and Full-Year 2017 Results and Announces Quarterly Dividend
finance.yahoo.com - February 15 at 8:46 AM
West Pharmaceutical Services, Inc. to Host Earnings CallWest Pharmaceutical Services, Inc. to Host Earnings Call
finance.yahoo.com - February 15 at 8:46 AM
West Pharmaceutical beats 4Q profit forecastsWest Pharmaceutical beats 4Q profit forecasts
finance.yahoo.com - February 15 at 8:46 AM
$416.20 Million in Sales Expected for West Pharmaceutical Services Inc. (WST) This Quarter$416.20 Million in Sales Expected for West Pharmaceutical Services Inc. (WST) This Quarter
www.americanbankingnews.com - February 9 at 1:40 PM
SelfDose™ Patient-Controlled Injector Named as Recipient of Pharmapack Exhibitor Innovation AwardSelfDose™ Patient-Controlled Injector Named as Recipient of Pharmapack Exhibitor Innovation Award
finance.yahoo.com - February 8 at 8:56 AM
Zacks: Brokerages Anticipate West Pharmaceutical Services Inc. (WST) Will Post Earnings of $0.62 Per ShareZacks: Brokerages Anticipate West Pharmaceutical Services Inc. (WST) Will Post Earnings of $0.62 Per Share
www.americanbankingnews.com - February 7 at 3:08 AM
West Pharmaceutical Services (WST) Scheduled to Post Earnings on WednesdayWest Pharmaceutical Services (WST) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - February 7 at 2:50 AM
West Pharmaceutical Services Inc. (WST) Given Average Rating of "Hold" by BrokeragesWest Pharmaceutical Services Inc. (WST) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - February 5 at 1:28 AM
West Pharmaceutical Services (WST) Upgraded by Zacks Investment Research to "Buy"West Pharmaceutical Services (WST) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - February 3 at 3:52 PM
West to Host Fourth-Quarter and Full-Year 2017 Conference CallWest to Host Fourth-Quarter and Full-Year 2017 Conference Call
finance.yahoo.com - February 1 at 9:12 AM
West Pharmaceutical Services (WST) Receives New Coverage from Analysts at Goldman Sachs GroupWest Pharmaceutical Services (WST) Receives New Coverage from Analysts at Goldman Sachs Group
www.americanbankingnews.com - January 28 at 5:10 PM
West Pharmaceutical Services (WST) Lifted to Hold at Zacks Investment ResearchWest Pharmaceutical Services (WST) Lifted to Hold at Zacks Investment Research
www.americanbankingnews.com - January 26 at 3:18 PM
Financial Analysis: West Pharmaceutical Services (WST) & AtriCure (ATRC)Financial Analysis: West Pharmaceutical Services (WST) & AtriCure (ATRC)
www.americanbankingnews.com - January 13 at 9:26 AM
West Pharmaceutical Services Inc. (WST) Receives Consensus Recommendation of "Hold" from AnalystsWest Pharmaceutical Services Inc. (WST) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - January 11 at 1:10 AM
Zacks Investment Research Lowers West Pharmaceutical Services (WST) to SellZacks Investment Research Lowers West Pharmaceutical Services (WST) to Sell
www.americanbankingnews.com - January 6 at 4:26 PM
Zacks: Analysts Expect West Pharmaceutical Services Inc. (WST) to Post $0.62 EPSZacks: Analysts Expect West Pharmaceutical Services Inc. (WST) to Post $0.62 EPS
www.americanbankingnews.com - January 4 at 9:52 AM
Daily Dividend Report: WST, FLS, DOC, WAYN, TCFCDaily Dividend Report: WST, FLS, DOC, WAYN, TCFC
www.msn.com - December 23 at 5:48 PM
Head to Head Comparison: West Pharmaceutical Services (WST) vs. Ocular Therapeutix (OCUL)Head to Head Comparison: West Pharmaceutical Services (WST) vs. Ocular Therapeutix (OCUL)
www.americanbankingnews.com - December 23 at 3:36 PM
Daily Dividend Report: WST, FLS, DOC, WAYN, TCFC - Presented by: The Aol. On NetworkDaily Dividend Report: WST, FLS, DOC, WAYN, TCFC - Presented by: The Aol. On Network
www.nasdaq.com - December 22 at 11:35 PM
West Pharmaceutical Services (WST) versus Asante Solutions (PUMP) Head to Head AnalysisWest Pharmaceutical Services (WST) versus Asante Solutions (PUMP) Head to Head Analysis
www.americanbankingnews.com - December 22 at 9:20 PM
West Announces Quarterly Dividend and Participation in Upcoming Investor ConferencesWest Announces Quarterly Dividend and Participation in Upcoming Investor Conferences
finance.yahoo.com - December 22 at 10:44 AM
West Pharmaceutical Services, Inc. (WST) Expected to Announce Quarterly Sales of $415.53 MillionWest Pharmaceutical Services, Inc. (WST) Expected to Announce Quarterly Sales of $415.53 Million
www.americanbankingnews.com - December 20 at 2:54 AM
 Brokerages Anticipate West Pharmaceutical Services, Inc. (WST) Will Announce Earnings of $0.61 Per Share Brokerages Anticipate West Pharmaceutical Services, Inc. (WST) Will Announce Earnings of $0.61 Per Share
www.americanbankingnews.com - December 18 at 9:24 PM
West Pharmaceutical Services, Inc. (WST) Receives Consensus Recommendation of "Hold" from AnalystsWest Pharmaceutical Services, Inc. (WST) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - December 17 at 1:50 AM
West Pharmaceutical Services, Inc. (WST) CFO William J. Federici Sells 21,000 SharesWest Pharmaceutical Services, Inc. (WST) CFO William J. Federici Sells 21,000 Shares
www.americanbankingnews.com - December 12 at 5:40 PM
West Pharmaceutical Services (WST) and Palomar Medical Technologies (PMTI) Financial ComparisonWest Pharmaceutical Services (WST) and Palomar Medical Technologies (PMTI) Financial Comparison
www.americanbankingnews.com - December 11 at 9:52 PM
What does West Pharmaceutical Services Inc’s (WST) Balance Sheet Tell Us Abouts Its Future?What does West Pharmaceutical Services Inc’s (WST) Balance Sheet Tell Us Abouts Its Future?
finance.yahoo.com - December 11 at 4:34 PM
West Pharmaceutical Services, Inc. (WST) Given Average Recommendation of "Hold" by BrokeragesWest Pharmaceutical Services, Inc. (WST) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 22 at 1:34 AM
Former Partner Rachael M. Bushey Rejoins Pepper Hamilton as Chair of Life Sciences and Vice Chair of Health Sciences DepartmentFormer Partner Rachael M. Bushey Rejoins Pepper Hamilton as Chair of Life Sciences and Vice Chair of Health Sciences Department
feeds.benzinga.com - November 21 at 11:58 AM
West Pharmaceutical (WST) Presents At Jefferies 2017 London Healthcare Conference - SlideshowWest Pharmaceutical (WST) Presents At Jefferies 2017 London Healthcare Conference - Slideshow
seekingalpha.com - November 18 at 10:23 AM
ETFs with exposure to West Pharmaceutical Services, Inc. : November 14, 2017ETFs with exposure to West Pharmaceutical Services, Inc. : November 14, 2017
finance.yahoo.com - November 16 at 8:42 AM
West Announces Upcoming Investor ConferenceWest Announces Upcoming Investor Conference
finance.yahoo.com - November 16 at 8:42 AM
Head to Head Contrast: West Pharmaceutical Services (WST) and Its RivalsHead to Head Contrast: West Pharmaceutical Services (WST) and Its Rivals
www.americanbankingnews.com - November 8 at 3:56 PM
West Pharmaceutical Services’ (WST) Robust Earnings Growth Make it a BuyWest Pharmaceutical Services’ (WST) Robust Earnings Growth Make it a Buy
investorplace.com - November 7 at 7:33 PM
West Pharmaceutical Services’ (WST) Robust Earnings Growth Make it a BuyWest Pharmaceutical Services’ (WST) Robust Earnings Growth Make it a Buy
investorplace.com - November 7 at 7:09 PM
Cardiovascular Systems (CSII) and West Pharmaceutical Services (WST) Financial AnalysisCardiovascular Systems (CSII) and West Pharmaceutical Services (WST) Financial Analysis
www.americanbankingnews.com - November 7 at 3:28 AM
Reviewing Cardiovascular Systems (CSII) and West Pharmaceutical Services (WST)Reviewing Cardiovascular Systems (CSII) and West Pharmaceutical Services (WST)
www.americanbankingnews.com - November 6 at 9:26 PM
West to Showcase New Extensions of the SmartDose® Drug Delivery Platform at the PDA Universe of Pre-filled Syringes and Injection DevicesWest to Showcase New Extensions of the SmartDose® Drug Delivery Platform at the PDA Universe of Pre-filled Syringes and Injection Devices
finance.yahoo.com - November 6 at 9:37 AM
ETFs with exposure to West Pharmaceutical Services, Inc. : November 3, 2017ETFs with exposure to West Pharmaceutical Services, Inc. : November 3, 2017
finance.yahoo.com - November 5 at 8:18 AM
West Pharmaceutical Services, Inc. :WST-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017West Pharmaceutical Services, Inc. :WST-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017
finance.yahoo.com - November 2 at 11:37 AM
FY2017 EPS Estimates for West Pharmaceutical Services, Inc. (WST) Lifted by Jefferies GroupFY2017 EPS Estimates for West Pharmaceutical Services, Inc. (WST) Lifted by Jefferies Group
www.americanbankingnews.com - October 30 at 1:42 AM

SEC Filings

West Pharmaceutical Services (NYSE:WST) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

West Pharmaceutical Services (NYSE:WST) Income Statement, Balance Sheet and Cash Flow Statement

Chart

West Pharmaceutical Services (NYSE WST) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.